IBM iConnect Access
K-Number: K182290 · 2018-09-25
ApplicantMerge Healthcare Incorporated
Decision Date2018-09-25
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent
Device Summary
IBM iConnect Access is a medical device manufactured by Merge Healthcare Incorporated. It received FDA 510(k) clearance on 2018-09-25 under approval number K182290. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the IBM iConnect Access?
IBM iConnect Access is a medical device that received FDA 510(k) clearance on 2018-09-25. It is manufactured by Merge Healthcare Incorporated. The 510(k) number is K182290.
When was IBM iConnect Access approved by the FDA?
IBM iConnect Access received FDA 510(k) clearance on 2018-09-25, under approval number K182290.
What company makes IBM iConnect Access?
IBM iConnect Access is manufactured by Merge Healthcare Incorporated.
What is the FDA product code for IBM iConnect Access?
The FDA product code for IBM iConnect Access is LLZ.
Other Devices by Merge Healthcare Incorporated
Related Devices (Code: LLZ)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.